198 related articles for article (PubMed ID: 24558429)
41. MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.
Cao L; Xie B; Yang X; Liang H; Jiang X; Zhang D; Xue P; Chen D; Shao Z
PLoS One; 2015; 10(7):e0133074. PubMed ID: 26177288
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
43. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
44. The suppressive role of SOX7 in hepatocarcinogenesis.
Wang C; Guo Y; Wang J; Min Z
PLoS One; 2014; 9(5):e97433. PubMed ID: 24816720
[TBL] [Abstract][Full Text] [Related]
45. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F
Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1.
Hu S; Tao R; Wang S; Wang C; Zhao X; Zhao H; Li L; Zhu S; He Y; Jiang X; Gao Y
Tumour Biol; 2015 Jul; 36(7):5467-72. PubMed ID: 25687183
[TBL] [Abstract][Full Text] [Related]
48. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2.
Jiang G; Wen L; Deng W; Jian Z; Zheng H
Biomed Pharmacother; 2017 Jun; 90():806-812. PubMed ID: 28437884
[TBL] [Abstract][Full Text] [Related]
49. MiR-942-3p Promotes the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting MBL2.
Xu CY; Dong JF; Chen ZQ; Ding GS; Fu ZR
Cancer Control; 2019; 26(1):1073274819846593. PubMed ID: 31046434
[TBL] [Abstract][Full Text] [Related]
50. LncRNA SNHG15 promotes hepatocellular carcinoma progression by sponging miR-141-3p.
Ye J; Tan L; Fu Y; Xu H; Wen L; Deng Y; Liu K
J Cell Biochem; 2019 Dec; 120(12):19775-19783. PubMed ID: 31310393
[TBL] [Abstract][Full Text] [Related]
51. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
Wang YG; Liu J; Shi M; Chen FX
J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
[TBL] [Abstract][Full Text] [Related]
52. Elevated expression of circular RNA circ_0008450 predicts dismal prognosis in hepatocellular carcinoma and regulates cell proliferation, apoptosis, and invasion via sponging miR-548p.
Zhang J; Chang Y; Xu L; Qin L
J Cell Biochem; 2019 Jun; 120(6):9487-9494. PubMed ID: 30556306
[TBL] [Abstract][Full Text] [Related]
53. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
[TBL] [Abstract][Full Text] [Related]
54. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
Lv J; Kong Y; Gao Z; Liu Y; Zhu P; Yu Z
Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864
[TBL] [Abstract][Full Text] [Related]
55. Exosomal miR-451a Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting LPIN1.
Zhao S; Li J; Zhang G; Wang Q; Wu C; Zhang Q; Wang H; Sun P; Xiang R; Yang S
Cell Physiol Biochem; 2019; 53(1):19-35. PubMed ID: 31162914
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of circ_0001445 decelerates hepatocellular carcinoma progression by regulating miR-942-5p/ALX4 axis.
Xu Q; Zhou L; Yang G; Meng F; Wan Y; Wang L; Zhang L
Biotechnol Lett; 2020 Dec; 42(12):2735-2747. PubMed ID: 32856218
[TBL] [Abstract][Full Text] [Related]
57. SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle.
Dong G; Zhang S; Shen S; Sun L; Wang X; Wang H; Wu J; Liu T; Wang C; Wang H; Lu T; Rao B; Ren Z
Cell Death Dis; 2020 Oct; 11(10):837. PubMed ID: 33037180
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-216b suppresses the cell growth of hepatocellular carcinoma by inhibiting Ubiquitin-specific peptidase 28 expression.
Zhang JF
Kaohsiung J Med Sci; 2020 Jun; 36(6):423-428. PubMed ID: 32053284
[TBL] [Abstract][Full Text] [Related]
59. MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells.
Ren JW; Li ZJ; Tu C
Int J Clin Exp Pathol; 2015; 8(6):6356-66. PubMed ID: 26261511
[TBL] [Abstract][Full Text] [Related]
60. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression.
Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J
Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
